N-epsilon-Lithocholyllysine
| Code | Size | Price |
|---|
| TAR-T33646-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
N-epsilon-Lithocholyllysine is a component of tissue-bound lithocholic acid.
CAS:
65236-49-9
Formula:
C30H52N2O4
Molecular Weight:
504.756
Purity:
0.98
SMILES:
[H][C@@]12CC[C@H]([C@H](C)CCC(=O)NCCCC[C@H](N)C(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C
References
Turjman N, Nair PP. Nature of tissue-bound lithocholic acid and its implications in the role of bile acids in carcinogenesis. Cancer Res. 1981 Sep;41(9 Pt 2):3761-3. PubMed PMID: 7020935.
Nair PP, Kessie G, Flanagan VP. Reaffirmation of the validity of enzymatic cleavage of lithocholic acid from N-epsilon-lithocholyl-L-lysine and N-alpha-CBZ-N-epsilon-lithocholyl-L-lysine. J Lipid Res. 1986 Aug;27(8):905-9. PubMed PMID: 2877042.
Nair PP, Kessie G, Patnaik R, Guidry C. Isolation and HPLC of N-epsilon-lithocholyl lysine as its fluorescamine and dimethylaminoazobenzene isothiocyanate derivatives. Steroids. 1994 Mar;59(3):212-6. PubMed PMID: 8048154.
Nair PP, Kessie G, Turjman N. Synthesis of N-epsilon-lithocholyl-L-lysine, a component of tissue-bound lithocholic acid, via lithocholyl-N-hydroxysuccinimide. J Steroid Biochem. 1985 Nov;23(5A):573-6. PubMed PMID: 4079375.